Answers are grounded in this paper and cite their sources.
Experimental study reveals efficient two-step synthesis of carbocyclic 5'-noruridine and promising anti-Epstein-Barr activity for its enantiomer, suggesting potential utility in antiviral therapies.
A convenient preparation of (1'R,2'S,3'R,4'S)-1-(2',3',4'-trihydroxycyclopent-1'-yl)-1H-uracil (carbocyclic 5'-noruridine, 1) is described in 2 steps from the palladium complex of (+)-(1R,4S)-4-hydroxy-2-cyclopenten-1-yl acetate (3) and the sodium salt of uracil (2). Compound 1 was sought as a previously unknown member of the series of carbocyclic 5'-nor nucleosides needed as moieties for new oligomers. With 1 available, its antiviral properties and those of its enantiomer (5) are reported with 5 showing promising activity towards Epstein-Barr virus.
No takes yet. Share an insight, caveat, or question.
Hegde et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: